Glycemic Control for Colorectal Cancer Survivors Compared to Those without Cancer in the Dutch Primary Care for Type 2 Diabetes:A Prospective Cohort Study
Simple Summary A growing number of colorectal cancer survivors live with type 2 diabetes, as a result of improved cancer diagnosis and treatment. These patients might have worse glycemic control after their cancer diagnosis, which may increase the risk of cardiovascular diseases. This prospective cohort study evaluated the quality of glycemic control for colorectal cancer survivors, as compared to those without cancer in Dutch primary care for diabetes. During a 10-year follow-up for 57,330 patients, there were 705 patients diagnosed with colorectal cancer. No clinically relevant difference on... Mehr ...
| Verfasser: | |
|---|---|
| Dokumenttyp: | Artikel |
| Erscheinungsdatum: | 2021 |
| Reihe/Periodikum: | de Haan-Du , J , Landman , G W D , Kleefstra , N , Schrijnders , D , Manders , M , Bos , A C R K , Tromp-van Driel , C , Denig , P , Groenier , K H & de Bock , G H 2021 , ' Glycemic Control for Colorectal Cancer Survivors Compared to Those without Cancer in the Dutch Primary Care for Type 2 Diabetes : A Prospective Cohort Study ' , Cancers , vol. 13 , no. 11 , 2767 . https://doi.org/10.3390/cancers13112767 |
| Schlagwörter: | cancer survivors / colorectal neoplasms / glycated hemoglobin a / primary healthcare / diabetes mellitus / type 2 / IMPACT |
| Sprache: | Englisch |
| Permalink: | https://search.fid-benelux.de/Record/base-26670418 |
| Datenquelle: | BASE; Originalkatalog |
| Powered By: | BASE |
| Link(s) : | https://hdl.handle.net/11370/2547d48b-8466-43d0-94ee-a40e2d69ea49 |
